Safety and efficacy results of durvalumab following sequential chemoradiotherapy (sCRT) in unresectable stage III NSCLC (PACIFIC 6)
Heilmann, M. Garassino, M. C. Mazieres, J. Chouaid, C. Bischoff, H. Reinmuth, N. Cove Smith, L. Mansy, T. Cortinovis, D. Migliorino, M. R.
Heilmann, M.
Garassino, M. C.
Mazieres, J.
Chouaid, C.
Bischoff, H.
Reinmuth, N.
Cove Smith, L.
Mansy, T.
Cortinovis, D.
Migliorino, M. R.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Heilmann M, Garassino MC, Mazieres J, Chouaid C, Bischoff H, Reinmuth N, et al. Safety and Efficacy Results of Durvalumab following Sequential Chemoradiotherapy (sCRT) in Unresectable Stage III NSCLC (PACIFIC 6). Oncology Research and Treatment. 2022 Sep;45(SUPPL 2):97-8. PubMed PMID: WOS:000864724100188.